Efficacy of Nifekalant in Patients With Wolff‐Parkinson‐White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings

BACKGROUND: The efficacy of nifekalant in preexcited atrial fibrillation (AF) has not been assessed. METHODS AND RESULTS: The study populations consisted of patients with sustained preexcited AF (n=51), paroxysmal supraventricular tachycardia (n=201), and persistent AF (n=87). Effects of intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jinzhu, Yu, Jianhua, Chen, Qi, Hu, Jianxin, Huang, Qianghui, Xia, Zhen, Xia, Zirong, Ju, Zhenzhen, Yuan, Ping, Fan, Siyang, Xiong, Qinmei, Zhu, Bo, Huang, Lin, You, Chunjiao, Bao, Huihui, Wu, Yanqing, Cheng, Xiaoshu, Li, Juxiang, Marian, Ali J., Hong, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662361/
https://www.ncbi.nlm.nih.gov/pubmed/31234695
http://dx.doi.org/10.1161/JAHA.119.012511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662361/
https://www.ncbi.nlm.nih.gov/pubmed/31234695
http://dx.doi.org/10.1161/JAHA.119.012511

Ejemplares similares